Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension

Jan A. Staessen, Lutgarde Thijs, Denis Clement, Christopher Davidson, Robert Fagard, Aapo Lehtonen, Giuseppe Mancia, Paolo Palatini, Eoin T. O'Brien, Gianfranco Parati, John Webster

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective: This long-term study investigated the widely accepted hypothesis that ambulatory pressure does not decrease in patients given placebo. Methods: One hundred and twelve older (=60 years) outpatients with isolated systolic hypertension were recruited. Treatment consisted of a placebo during a 3-month baseline period and long-term follow-up. Results: At baseline, on placebo treatment, clinic systolic/diastolic (SBP/DBP) blood pressure (±SD) averaged 176±12/86±7mmHg and 24-h SBP/DBP 151 ± 15/81 ± 10 mmHg. These pressures were unaltered in 51 patients in whom the baseline measurements were repeated after a further month on placebo. After the 112 patients had received placebo for 1 year (median), clinic SBP/DBP fell by 6.6±15.9 (P

Original languageEnglish
Pages (from-to)1035-1039
Number of pages5
JournalJournal of Hypertension
Volume12
Issue number9
Publication statusPublished - 1994

Fingerprint

Placebos
Hypertension
Pressure
Therapeutics
Outpatients
Blood Pressure

Keywords

  • Ambulatory blood pressure
  • Conventional blood pressure
  • Placebo

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Endocrinology

Cite this

Staessen, J. A., Thijs, L., Clement, D., Davidson, C., Fagard, R., Lehtonen, A., ... Webster, J. (1994). Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. Journal of Hypertension, 12(9), 1035-1039.

Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. / Staessen, Jan A.; Thijs, Lutgarde; Clement, Denis; Davidson, Christopher; Fagard, Robert; Lehtonen, Aapo; Mancia, Giuseppe; Palatini, Paolo; O'Brien, Eoin T.; Parati, Gianfranco; Webster, John.

In: Journal of Hypertension, Vol. 12, No. 9, 1994, p. 1035-1039.

Research output: Contribution to journalArticle

Staessen, JA, Thijs, L, Clement, D, Davidson, C, Fagard, R, Lehtonen, A, Mancia, G, Palatini, P, O'Brien, ET, Parati, G & Webster, J 1994, 'Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension', Journal of Hypertension, vol. 12, no. 9, pp. 1035-1039.
Staessen JA, Thijs L, Clement D, Davidson C, Fagard R, Lehtonen A et al. Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. Journal of Hypertension. 1994;12(9):1035-1039.
Staessen, Jan A. ; Thijs, Lutgarde ; Clement, Denis ; Davidson, Christopher ; Fagard, Robert ; Lehtonen, Aapo ; Mancia, Giuseppe ; Palatini, Paolo ; O'Brien, Eoin T. ; Parati, Gianfranco ; Webster, John. / Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. In: Journal of Hypertension. 1994 ; Vol. 12, No. 9. pp. 1035-1039.
@article{e2e29c1a629a442f80bdc9d3346c1654,
title = "Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension",
abstract = "Objective: This long-term study investigated the widely accepted hypothesis that ambulatory pressure does not decrease in patients given placebo. Methods: One hundred and twelve older (=60 years) outpatients with isolated systolic hypertension were recruited. Treatment consisted of a placebo during a 3-month baseline period and long-term follow-up. Results: At baseline, on placebo treatment, clinic systolic/diastolic (SBP/DBP) blood pressure (±SD) averaged 176±12/86±7mmHg and 24-h SBP/DBP 151 ± 15/81 ± 10 mmHg. These pressures were unaltered in 51 patients in whom the baseline measurements were repeated after a further month on placebo. After the 112 patients had received placebo for 1 year (median), clinic SBP/DBP fell by 6.6±15.9 (P",
keywords = "Ambulatory blood pressure, Conventional blood pressure, Placebo",
author = "Staessen, {Jan A.} and Lutgarde Thijs and Denis Clement and Christopher Davidson and Robert Fagard and Aapo Lehtonen and Giuseppe Mancia and Paolo Palatini and O'Brien, {Eoin T.} and Gianfranco Parati and John Webster",
year = "1994",
language = "English",
volume = "12",
pages = "1035--1039",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension

AU - Staessen, Jan A.

AU - Thijs, Lutgarde

AU - Clement, Denis

AU - Davidson, Christopher

AU - Fagard, Robert

AU - Lehtonen, Aapo

AU - Mancia, Giuseppe

AU - Palatini, Paolo

AU - O'Brien, Eoin T.

AU - Parati, Gianfranco

AU - Webster, John

PY - 1994

Y1 - 1994

N2 - Objective: This long-term study investigated the widely accepted hypothesis that ambulatory pressure does not decrease in patients given placebo. Methods: One hundred and twelve older (=60 years) outpatients with isolated systolic hypertension were recruited. Treatment consisted of a placebo during a 3-month baseline period and long-term follow-up. Results: At baseline, on placebo treatment, clinic systolic/diastolic (SBP/DBP) blood pressure (±SD) averaged 176±12/86±7mmHg and 24-h SBP/DBP 151 ± 15/81 ± 10 mmHg. These pressures were unaltered in 51 patients in whom the baseline measurements were repeated after a further month on placebo. After the 112 patients had received placebo for 1 year (median), clinic SBP/DBP fell by 6.6±15.9 (P

AB - Objective: This long-term study investigated the widely accepted hypothesis that ambulatory pressure does not decrease in patients given placebo. Methods: One hundred and twelve older (=60 years) outpatients with isolated systolic hypertension were recruited. Treatment consisted of a placebo during a 3-month baseline period and long-term follow-up. Results: At baseline, on placebo treatment, clinic systolic/diastolic (SBP/DBP) blood pressure (±SD) averaged 176±12/86±7mmHg and 24-h SBP/DBP 151 ± 15/81 ± 10 mmHg. These pressures were unaltered in 51 patients in whom the baseline measurements were repeated after a further month on placebo. After the 112 patients had received placebo for 1 year (median), clinic SBP/DBP fell by 6.6±15.9 (P

KW - Ambulatory blood pressure

KW - Conventional blood pressure

KW - Placebo

UR - http://www.scopus.com/inward/record.url?scp=0028142747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028142747&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 1035

EP - 1039

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 9

ER -